17.10.2016 • NewsElaine BurridgeSolvayOLED

Solvay Sells OLED Patents to Nissan

(c) Solvay
(c) Solvay

Solvay has agreed to sell most of its organic light emitting diode (OLED) patent portfolio to Japan’s Nissan Chemical Industries for an undisclosed sum. The patents are related to the production of soluble HIL and HTL materials. The sale follows a strategic analysis of the organic electronics market that the Belgian chemical producer said showed new display technologies being delayed.

As a consequence, Solvay, which gained several OLED activities with the acquisition of US technology company Plextronics in 2014, said it has decided to stop its research activities in this area and has started a value assessment of its related patent portfolio. The company added that it will continue to transfer its patents and technologies and use its resources for other research programs instead.

Solvay’s move is a sign that the OLED market is consolidating. The Belgian player’s exit follows BASF’s sale of its OLED intellectual property to UDC Ireland in June of this year after stopping its research activities at the end of 2015. OLED’s superior image quality have gained much interest for use in digital displays, and Nissan said applications are expected to expand.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.